These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23233586)

  • 41. HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis.
    Robin M; Porcher R; Ruggeri A; Blaise D; Wolschke C; Koster L; Angelucci E; Stölzel F; Potter V; Yakoub-Agha I; Koc Y; Ciceri F; Finke J; Labussière-Wallet H; Cascon MJP; Verbeek M; Rambaldi A; Cornelissen JJ; Chevallier P; Radia R; Nagler A; Fegueux N; Gluckman E; de Witte T; Kröger N
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):114-120. PubMed ID: 30172776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide.
    Fuchs EJ
    Bone Marrow Transplant; 2015 Jun; 50 Suppl 2(0 2):S31-6. PubMed ID: 26039204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin.
    Finke J; Schmoor C; Lang H; Potthoff K; Bertz H
    J Clin Oncol; 2003 Feb; 21(3):506-13. PubMed ID: 12560442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantation.
    Luo XH; Chang YJ; Huang XJ
    J Immunol Res; 2014; 2014():631951. PubMed ID: 24864269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014.
    Al Malki MM; Horowitz M; Handgretinger R; Leung W; Roy DC; Huang XJ; Fuchs E; Locatelli F; Blaise D; Mineishi S; Martelli M; Miller J; June C; Ai HS; Luznik L; Mavilio D; Lugli E; van den Brink MRM; Champlin RE; Ciurea SO
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):594-604. PubMed ID: 26806585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation.
    Baumeister SHC; Rambaldi B; Shapiro RM; Romee R
    Front Immunol; 2020; 11():191. PubMed ID: 32117310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
    Blaise D; Fürst S; Crocchiolo R; El-Cheikh J; Granata A; Harbi S; Bouabdallah R; Devillier R; Bramanti S; Lemarie C; Picard C; Chabannon C; Weiller PJ; Faucher C; Mohty B; Vey N; Castagna L
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):119-24. PubMed ID: 26341397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Haploidentical cord transplantation-The best of both worlds.
    van Besien K; Childs R
    Semin Hematol; 2016 Oct; 53(4):257-266. PubMed ID: 27788764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haploidentical stem cell transplant with post-transplantation cyclophosphamide and mini-dose methotrexate in children.
    Medina D; Estacio M; Rosales M; Manzi E
    Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):208-213. PubMed ID: 32224144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mismatched HLA-DRB3 Can Induce a Potent Immune Response After HLA 10/10 Matched Stem Cell Transplantation.
    van Balen P; van Luxemburg-Heijs SAP; van de Meent M; van Bergen CAM; Halkes CJM; Jedema I; Falkenburg JHF
    Transplantation; 2017 Dec; 101(12):2850-2854. PubMed ID: 28252558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
    Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Haploidentical hematopoietic stem cell transplant: How to choose the best donor? Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Dubois V; Amokrane K; Beguin Y; Bruno B; Chevallier P; Delbos F; Devillier R; Giannoli C; Guidicelli G; Harif M; Loiseau P; Rouzaire PO; Varlet P; Yakoub-Agha I; Nguyen S
    Bull Cancer; 2020 Jan; 107(1S):S72-S84. PubMed ID: 31586527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.
    How J; Slade M; Vu K; DiPersio JF; Westervelt P; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Romee R
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):648-653. PubMed ID: 28087457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two Occurrences of Leukemia Relapse Due to Mismatched HLA Loss After Haploidentical Stem Cell Transplantation From Different Family Donors With KIR Ligand Mismatch.
    Sano H; Mochizuki K; Kobayashi S; Ono S; Ikeda K; Ohto H; Kikuta A
    J Pediatr Hematol Oncol; 2020 Mar; 42(2):e104-e106. PubMed ID: 30807398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
    Kindwall-Keller TL; Ballen KK
    Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation.
    Luznik L; O'Donnell PV; Fuchs EJ
    Semin Oncol; 2012 Dec; 39(6):683-93. PubMed ID: 23206845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults.
    Kasamon YL; Bolaños-Meade J; Prince GT; Tsai HL; McCurdy SR; Kanakry JA; Rosner GL; Brodsky RA; Perica K; Smith BD; Gladstone DE; Swinnen LJ; Showel MM; Matsui WH; Huff CA; Borrello I; Pratz KW; McDevitt MA; Gojo I; Dezern AE; Shanbhag S; Levis MJ; Luznik L; Ambinder RF; Fuchs EJ; Jones RJ
    J Clin Oncol; 2015 Oct; 33(28):3152-61. PubMed ID: 26261255
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.
    Ghosh N; Karmali R; Rocha V; Ahn KW; DiGilio A; Hari PN; Bachanova V; Bacher U; Dahi P; de Lima M; D'Souza A; Fenske TS; Ganguly S; Kharfan-Dabaja MA; Prestidge TD; Savani BN; Smith SM; Sureda AM; Waller EK; Jaglowski S; Herrera AF; Armand P; Salit RB; Wagner-Johnston ND; Fuchs E; Bolaños-Meade J; Hamadani M
    J Clin Oncol; 2016 Sep; 34(26):3141-9. PubMed ID: 27269951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune reconstitution after haploidentical hematopoietic stem cell transplantation.
    Chang YJ; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):440-9. PubMed ID: 24315844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.